Rising drug prices in Brazil during COVID-19 pandemic: another threat to people's health
Braz. J. Pharm. Sci. (Online)
; 58: e20863, 2022. tab
Article
in En
|
LILACS-Express
| LILACS
| ID: biblio-1420412
Responsible library:
BR1.1
ABSTRACT
Abstract The COVID-19 pandemic puts the healthcare systems at risk due to the still uncertain operational and financial impacts of it. The difficult economic conditions of the population also call for more attention from government officials to define strategies that guarantee access to health services and products. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fundamental to reducing disruption of the healthcare system. Increasing drug prices during the pandemic is definitely not a strategy that contributes to access. In this sense, this commentary presents a criticism of a decision by the Brazilian government that may impact the availability in health services and the population's access to medicines necessary for the maintenance of life.
Full text:
1
Collection:
01-internacional
Database:
LILACS
Type of study:
Health_economic_evaluation
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Braz. J. Pharm. Sci. (Online)
Journal subject:
Farmacologia
/
Teraputica
/
Toxicologia
Year:
2022
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil